Boehringer Ingelheim - March 2022 - case study 1

Start date:

Identification and optimisation of a risk stratified cohort of patients with Type 2 diabetes (T2D) across East Belfast Federation through the delivery of a pharmacist-led virtual and face to face service

Last modified: 29 May 2024

Last reviewed: 29 May 2024